Skip to content

13F-HR filed by Ishara Investments LP

Ishara Investments LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 15:11:09 UTC, with 41 holding rows worth $121,006,810.

Accession
0002111609-26-000005
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 41 entries on the cover page, a total value of $121,006,810 stated on the cover page (in dollars after the unit check, H1), rows summing to $121,006,810 with VALUE read as dollars as filed, 13F file number 028-26490. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TRAVERE THERAPEUTICS INC89422G107COM145,000$8,537,600dollars as filed
CYTOKINETICS INC23282W605COM NEW128,000$8,436,480dollars as filed
BRIDGEBIO PHARMA INC10806X102COM100,000$6,580,000dollars as filed
ACADIA PHARMACEUTICALS INC004225108COM320,000$6,448,000dollars as filed
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK70,000$5,502,700dollars as filed
PTC THERAPEUTICS INC69366J200COM80,000$5,182,400dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW17,000$4,950,910dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK150,000$4,843,500dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM180,000$4,757,400dollars as filed
ANNEXON INC03589W102COM1,120,000$4,737,600dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock8,000$4,335,120dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK160,000$3,891,200dollars as filed
XERIS BIOPHARMA HOLDINGS INC98422E103COM400,000$3,824,000dollars as filed
CELCUITY INC15102K100COM48,000$3,816,960dollars as filed
DBV TECHNOLOGIES S A23306J309SPONSORED ADS270,000$3,175,200dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM150,000$3,088,500dollars as filed
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK1,080,000$2,991,600dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM48,000$2,880,000dollars as filed
BIOGEN INC COM09062X103Stock12,000$2,710,560dollars as filed
MINERALYS THERAPEUTICS INC603170101COM100,000$2,513,000dollars as filed
LIGAND PHARMACEUTICALS INC53220K504COM NEW8,000$2,498,960dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM160,000$2,404,800dollars as filed
VAXCYTE INC COM92243G108Stock40,000$2,276,000dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM160,000$2,155,200dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock10,000$1,843,900dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS160,000$1,748,800dollars as filed
BEAM THERAPEUTICS INC07373V105COM70,000$1,711,500dollars as filed
BIOHAVEN LTDG1110E107COM120,000$1,602,000dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM1,000$1,503,000dollars as filedput
CONTINEUM THERAPEUTICS INC CL A21217B100Stock108,000$1,449,360dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share40,000$1,427,000dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM8,000$1,134,720dollars as filed
MONOPAR THERAPEUTICS INC61023L207COMMON STOCK12,000$956,040dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock80,000$936,000dollars as filed
ARS PHARMACEUTICALS INC82835W108COM200,000$862,000dollars as filed
IONIS PHARMACEUTICALS INC COM462222100Stock16,000$714,400dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM80,000$691,200dollars as filed
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK320,000$600,000dollars as filed
Wave Life Sciences Inc.94352A104COM160,000$592,000dollars as filed
SAVARA INC805111101COM80,000$412,800dollars as filed
Gossamer Bio, Inc.38341P201Common Stock, $0.0001 par value per share24,000$284,400dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0002111609-26-000005this filing2026-11-16